decisionhealth Newsletters, Part B News - 2004 Issue 9 (September)
17 specialties urge CMS to release ASP data for all drugs
Subscribe or sign in to view the full article.
Article Overview
This news item explains why multiple specialty organizations asked CMS to make broader preliminary average sales price data available before the new Medicare drug payment system takes effect. It also notes related CMS rulemaking on how ASP is calculated and why the timing and completeness of payment information matter for physicians and practice administrators.
Why This Topic Matters
Readers who bill or manage office-administered drug services need to understand Medicare payment policy changes and the availability of pricing data that may affect financial planning and reimbursement expectations.
What You Will Learn
- Why specialty societies wanted CMS to release additional preliminary drug pricing data
- How Medicare Part B drug payment changes were affecting physician practices
- What CMS rulemaking addressed regarding average sales price calculation
- Which stakeholder groups were involved in the advocacy effort
Who Should Read This
- Physicians
- Practice managers
- Medical coders
- Billing staff
- Revenue cycle professionals
- Specialty society staff
Subscribe or sign in to view the full article.
Quick, Current, Complete - www.findacode.com